The European drug landscape in 2013 – Highlights from the EMCDDA's European drug report

Author： Mounteney Jane   Zobel Frank   Griffiths Paul  

Publisher： Informa Healthcare

ISSN： 1465-3370

Source： Drugs: Education, Prevention & Policy, Vol.20, Iss.5, 2013-10, pp. : 425-426

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug policy harmonization and the European Union, by Caroline Chatwin

By Frank Vibeke Asmussen  

Drugs: Education, Prevention & Policy, Vol. 19, Iss. 3, 2012-06 ,pp. : 270-271

Informa Healthcare

Access to resources Recommend Favorite

The effects of EU enlargement on European drug policy

By Chatwin Caroline  

Drugs: Education, Prevention & Policy, Vol. 11, Iss. 6, 2004-12 ,pp. : 437-448

Informa Healthcare

Access to resources Recommend Favorite

The global crisis and the changing European industrial landscape

By Bellofiore Riccardo   Garibaldo Francesco  

International Journal of Management Concepts and Philosophy, Vol. 5, Iss. 3, 2011-11 ,pp. : 273-289

Inderscience Publishers

Access to resources Recommend Favorite

EMCDDA INSIGHTS 11, New heroin-assisted drug treatment - Recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond, John Strang, Teodora Groshkova and Nicola Metrebian

By Frank Vibeke Asmussen  

Drugs: Education, Prevention & Policy, Vol. 20, Iss. 2, 2013-04 ,pp. : 160-161

Informa Healthcare

Access to resources Recommend Favorite

The European Commission's Report on Company Income Taxation: What the EU Can Learn from the Experience of the US States

By Hellerstein Walter  

International Tax and Public Finance, Vol. 11, Iss. 2, 2004-03 ,pp. : 199-220

Springer Publishing Company

Access to resources Recommend Favorite